Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

EZZ Life Science cracks the US supplements market: A game changer or a calculated gamble?

  • In News
  • June 25, 2024
  • Sidra Surmed
EZZ Life Science cracks the US supplements market: A game changer or a calculated gamble?

Imagine getting access to high-quality supplements for brain focus or essential minerals for your family, all with the backing of a brand that’s shaking up the industry. Yes, that’s the kind of  potential impact we are talking about. The US expansion of EZZ Life Science (ASX: EZZ) may be a game-changer for American consumers seeking effective and efficient health solutions. 

Do you recall the Australian life sciences company’s goal of discovering the mysteries of human health? It always felt a touch grandiose, hinting at something more substantial brewing beneath the surface. Now, with their sights set on the US, the world’s biggest health supplement market.

EZZ’s supplements have secured FDA approval for nine of their health products in the FDA’s food category. This grants those products entry into the world’s biggest health supplement market, valued at USD $23.8 billion in 2023.

“We are thrilled to have received FDA approval for a range of our products. This is a monumental achievement for EZZ and a validation of our commitment to excellence in product quality and innovation,” said Glenn Cross, Chairman of EZZ Life Science 

Entering the US market is a pivotal part of our plans for future growth, and we are excited about the opportunities this approval presents. We look forward to bringing our high-quality products to consumers in the United States and continuing to drive value for our shareholders.”

The nine products approved by the FDA selected by the Company due to their success in other markets are: EZZ Brain Focus, EZZ Children’s Eye Health, EZZ Children’s Essential Minerals , EZZ Magnesium Plus, EZZ Aloe Vera Probiotic Capsules, EZZ Liver Detox, EZZ Joint Energy Boost Tablets, EZZ Men’s Performance. EZZ plans to establish its online presence by selling these products online, similar to how they do in other countries. 

When compared to more established brands in the supplements industry, EZZ is a relatively new company. Brand loyalty is a major factor in the saturation of the US market, a roadblock EZZ will need to overcome to be competitive. . 

EZZ’s US expansion could transform the landscape of the health supplement industry. Their scientifically backed formulae and distinct brand image will be interesting to see how they fare in the competitive US market.

Additionally, with their active expansion of the distribution network, EZZ’s revenue continues to climb, with customer receipts of 23.6 million in the March quarter (Q3 FY24), a significant increase of 111% compared to the same period last year. EZZ maintains a strong financial position with a cash balance of 14.5 million at the end of March 2024 and no outstanding debt. Further commercial sales work is being undertaken by EZZ through their active participation in trade shows and influencer marketing strategies. 

  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  •  
  •  
  •  
  •  
  • asx ezz
  • EZZ
  • ezz life science
  • Glenn Cross
  • health supplements
  • supplements
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    March 26, 2025, 6:20 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/mineral-supplements

    Reply
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.